XML 53 R42.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements and Investments - Additional Information (Detail) - USD ($)
9 Months Ended
Oct. 01, 2020
Apr. 30, 2018
Sep. 30, 2021
Jun. 30, 2021
Spinal Kinetics [Member]        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Milestone achievement period   5 years    
Consideration transferred     $ 18,400,000  
Payment for contingent consideration liability     30,000,000.0  
Maximum [Member] | Spinal Kinetics [Member]        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Future milestone payments   $ 60,000,000.0    
US Food And Drug Administration [Member] | Spinal Kinetics [Member]        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Future milestone payments   15,000,000.0    
Revenue Milestone [Member]        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Future milestone payments       $ 15,000.0
Revenue Milestone [Member] | Spinal Kinetics [Member]        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Future milestone payments   $ 45,000,000.0    
Neo Medical [Member]        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Convertible loans $ 4,600,000      
Maturity date Oct. 01, 2024      
Carrying value of investment     5,000,000.0  
Convertible loan credit losses     $ 0  
Neo Medical [Member] | Preferred Stock        
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]        
Amount of Preferred stock consideration $ 5,000,000.0